NEU 4.98% $20.21 neuren pharmaceuticals limited

Competitors to Daybue, page-8

  1. 896 Posts.
    lightbulb Created with Sketch. 331
    We will be treating multiple ailments by the time any of these are approved. And if/when they are they will most likely compliment trofinetide rather than replace it. These are mostly all treatments, not cures! Gene therapy may be a cure but it is at least 10 years away, if ever. Also gene therapy can only specifically target one ailment at a time whereas our drugs can potentially treat almost all neurological disorders.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.21
Change
-1.060(4.98%)
Mkt cap ! $2.583B
Open High Low Value Volume
$20.98 $21.06 $20.14 $6.308M 308.8K

Buyers (Bids)

No. Vol. Price($)
1 3926 $20.19
 

Sellers (Offers)

Price($) Vol. No.
$20.21 388 1
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.